Obstetrics & Gynecology Doctors in Fot Stewart, GA Accepting Medicare
1 Obstetrics & Gynecology doctors found. Showing 1 - 1
 Dr. Shannon Fay Renfrow, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1061 Harmon Ave, Fot Stewart, GA 31314 Phone: 912-435-6965 |
News Archive
GSK begins shipments of Fluarix and FluLaval to U.S. customers for 2008-2009 flu season
GlaxoSmithKline has announced that it will begin shipment of Flulaval [Influenza Virus Vaccine] and Fluarix [Influenza Virus Vaccine] to U.S. customers for the 2008-2009 influenza season.
DMAA stimulant does not originate from natural substances
A new study published in the journal Drug Testing and Analysis found that DMAA, a stimulant often found in many nutritional and sports supplements, does not originate from natural substances and is actually comprised of synthetic compounds.
Scientists develop new type of carrier that combines photosensitivity and magnetism to fight cancer
By combining, in a liposome, magnetic nanoparticles and photosensitizers that are simultaneously and remotely activated by external physical stimuli (a magnetic field and light), scientists at the Laboratoire Matière et Systèmes Complexes (CNRS/Université Paris Diderot) and the Laboratoire Physicochimie des Electrolytes et Nanosystèmes Interfaciaux (CNRS/UPMC), obtained total tumor regression in mice.
State roundup: Mass. grapples with EHR privacy issues
Providers in separate networks are preparing to share patients' records more widely online - to better coordinate care and cut wasteful spending. This will probably intensify the debate about what should and should not be shared, as well as fears about the unauthorized release of patient information.
Belatacept costimulation blocker can prevent rejection of new organs by the immune system
Initial results of a study conducted at 100 centers worldwide indicate that belatacept, a first-in-class costimulation blocker can prevent the immune system rejecting new organs. The results also suggest that it may provide similar patient and graft survival to cyclosporine but with fewer side effects and superior kidney function after 12 months. The study, published today in the American Journal of Transplantation, provides the first findings to come from BENEFIT (Belatacept Evaluation of Nephroprotection and Efficacy as First-line Immunosuppression Trial).
› Verified 9 days ago